• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尼罗红是细胞色素P450 3A4的一种荧光变构底物。

Nile Red is a fluorescent allosteric substrate of cytochrome P450 3A4.

作者信息

Lampe Jed N, Fernandez Cristina, Nath Abhinav, Atkins William M

机构信息

Department of Medicinal Chemistry, Box 357610, University of Washington, Seattle, Washington 98195-7610, USA.

出版信息

Biochemistry. 2008 Jan 15;47(2):509-16. doi: 10.1021/bi7013807. Epub 2007 Dec 20.

DOI:10.1021/bi7013807
PMID:18092806
Abstract

Cytochrome P450 3A4 (CYP3A4) plays a critical role in the metabolism of many drugs. CYP3A4 exhibits extraordinary substrate promiscuity and unusual allosteric kinetics. In addition, many CYPs catalyze sequential oxidations on a single substrate, but in most cases, mechanistic details of these processes are not well-established. As a result, in vivo clearance of many drugs and their metabolites is difficult to predict on the basis of the complex in vitro kinetics, and new in vitro probes are required to understand these behaviors. The near-IR fluorescent probe Nile Red, which has strong solvatochromic behavior, was investigated as a probe of allostery and sequential metabolism with CYP3A4. Nile Red binds with apparent Kd values of 0.05 and 2.3 muM, based on a sigmoidal dependence of heme spin state on Nile Red concentration, where the first equivalent of Nile Red increased the high-spin fraction by only 13% of the total change at saturation. Mass spectrometry analysis indicates that Nile Red is metabolized sequentially by CYP3A4 to the N-monoethyl and N-desethyl products, confirming that the immediate vicinity of the heme iron is one binding site. In the presence of CYP3A4, steady-state fluorescence emission and excitation spectra, as well as excited-state lifetimes at varying Nile Red concentrations, indicate a high-affinity site that modulates the fluorescent properties of Nile Red. The Nile Red binding site is competitively eliminated by itraconazole, which is a high-affinity ligand known to coordinate to the heme iron. Together, the data suggest that Nile Red binds to the active site with high affinity ( approximately 50 nM), where it is desolvated in a low-dielectric environment. In addition, Nile Red is sequentially oxidized at rates comparable to or faster than those of other in vitro probes, which emphasizes its utility in the further examination of this important kinetic phenomenon in vitro.

摘要

细胞色素P450 3A4(CYP3A4)在许多药物的代谢过程中起着关键作用。CYP3A4表现出非凡的底物选择性和异常的变构动力学。此外,许多细胞色素P450酶对单一底物催化连续氧化反应,但在大多数情况下,这些过程的机制细节尚未完全明确。因此,基于复杂的体外动力学很难预测许多药物及其代谢产物的体内清除率,需要新的体外探针来了解这些行为。具有强溶剂化显色行为的近红外荧光探针尼罗红被研究作为CYP3A4变构和连续代谢的探针。基于血红素自旋状态对尼罗红浓度的S形依赖性,尼罗红的表观解离常数(Kd)值为0.05和2.3 μM,其中第一个当量的尼罗红使高自旋分数仅增加到饱和时总变化的13%。质谱分析表明,尼罗红被CYP3A4依次代谢为N-单乙基和N-去乙基产物,证实血红素铁的紧邻区域是一个结合位点。在存在CYP3A4的情况下,尼罗红在不同浓度下的稳态荧光发射和激发光谱以及激发态寿命表明存在一个高亲和力位点,该位点调节尼罗红的荧光特性。尼罗红结合位点被伊曲康唑竞争性消除,伊曲康唑是一种已知与血红素铁配位的高亲和力配体。综合这些数据表明,尼罗红以高亲和力(约50 nM)结合到活性位点,在低介电环境中发生去溶剂化。此外,尼罗红的连续氧化速率与其他体外探针相当或更快,这突出了其在体外进一步研究这一重要动力学现象中的实用性。

相似文献

1
Nile Red is a fluorescent allosteric substrate of cytochrome P450 3A4.尼罗红是细胞色素P450 3A4的一种荧光变构底物。
Biochemistry. 2008 Jan 15;47(2):509-16. doi: 10.1021/bi7013807. Epub 2007 Dec 20.
2
Spectral resolution of a second binding site for Nile Red on cytochrome P4503A4.尼罗红在细胞色素P4503A4上第二个结合位点的光谱分辨率。
Arch Biochem Biophys. 2008 Jun 1;474(1):198-204. doi: 10.1016/j.abb.2008.03.017. Epub 2008 Mar 25.
3
Sigmoidal kinetic model for two co-operative substrate-binding sites in a cytochrome P450 3A4 active site: an example of the metabolism of diazepam and its derivatives.细胞色素P450 3A4活性位点中两个协同底物结合位点的S形动力学模型:地西泮及其衍生物代谢的一个例子。
Biochem J. 1999 Jun 15;340 ( Pt 3)(Pt 3):845-53.
4
Time-resolved fluorescence studies of heterotropic ligand binding to cytochrome P450 3A4.异源配体与细胞色素P450 3A4结合的时间分辨荧光研究。
Biochemistry. 2006 Oct 10;45(40):12204-15. doi: 10.1021/bi060083h.
5
Pyrene.pyrene complexes at the active site of cytochrome P450 3A4: evidence for a multiple substrate binding site.细胞色素P450 3A4活性位点处的芘-芘复合物:多底物结合位点的证据。
J Am Chem Soc. 2002 Oct 9;124(40):11866-7. doi: 10.1021/ja027552x.
6
Allosteric effects on substrate dissociation from cytochrome P450 3A4 in nanodiscs observed by ensemble and single-molecule fluorescence spectroscopy.通过整体和单分子荧光光谱法观察纳米盘对细胞色素P450 3A4底物解离的变构效应。
J Am Chem Soc. 2008 Nov 26;130(47):15746-7. doi: 10.1021/ja805772r.
7
N,N-diethyl-2-[4-(phenylmethyl)phenoxy] ethanamine (DPPE) a chemopotentiating and cytoprotective agent in clinical trials: interaction with histamine at cytochrome P450 3A4 and other isozymes that metabolize antineoplastic drugs.N,N-二乙基-2-[4-(苯甲基)苯氧基]乙胺(DPPE),一种处于临床试验阶段的化学增效和细胞保护剂:在细胞色素P450 3A4及其他代谢抗肿瘤药物的同工酶上与组胺的相互作用。
Cancer Chemother Pharmacol. 2000;45(4):298-304. doi: 10.1007/s002800050044.
8
The thermodynamic landscape of testosterone binding to cytochrome P450 3A4: ligand binding and spin state equilibria.睾酮与细胞色素P450 3A4结合的热力学态势:配体结合与自旋态平衡
Biochemistry. 2005 Feb 1;44(4):1353-66. doi: 10.1021/bi0481390.
9
Allosteric mechanisms in cytochrome P450 3A4 studied by high-pressure spectroscopy: pivotal role of substrate-induced changes in the accessibility and degree of hydration of the heme pocket.通过高压光谱研究细胞色素P450 3A4中的变构机制:底物诱导的血红素口袋可及性和水合程度变化的关键作用。
Biochemistry. 2007 Jul 3;46(26):7852-64. doi: 10.1021/bi602400y. Epub 2007 Jun 8.
10
Steroid bioconjugation to a CYP3A4 allosteric site and its effect on substrate binding and coupling efficiency.甾体化合物与 CYP3A4 变构部位的生物缀合及其对底物结合和偶联效率的影响。
Arch Biochem Biophys. 2018 Sep 1;653:90-96. doi: 10.1016/j.abb.2018.06.014. Epub 2018 Jun 26.

引用本文的文献

1
Drug metabolism of ciprofloxacin, ivacaftor, and raloxifene by Pseudomonas aeruginosa cytochrome P450 CYP107S1.铜绿假单胞菌细胞色素 P450 CYP107S1 对环丙沙星、依伐卡托和雷洛昔芬的药物代谢。
J Biol Chem. 2024 Aug;300(8):107594. doi: 10.1016/j.jbc.2024.107594. Epub 2024 Jul 18.
2
Steroid 17α-hydroxylase/17, 20-lyase (cytochrome P450 17A1).甾体 17α-羟化酶/17,20-裂合酶(细胞色素 P45017A1)。
Methods Enzymol. 2023;689:39-63. doi: 10.1016/bs.mie.2023.04.001. Epub 2023 Apr 25.
3
Development of Small-Molecule Fluorescent Probes Targeting Enzymes.
小分子荧光探针靶向酶的研发。
Molecules. 2022 Jul 14;27(14):4501. doi: 10.3390/molecules27144501.
4
Midazolam as a Probe for Heterotropic Drug-Drug Interactions Mediated by CYP3A4.咪达唑仑作为由 CYP3A4 介导的异质药物-药物相互作用的探针。
Biomolecules. 2022 Jun 20;12(6):853. doi: 10.3390/biom12060853.
5
Characterization of fluorescent probe substrates to develop an efficient high-throughput assay for neonatal hepatic CYP3A7 inhibition screening.鉴定荧光探针底物以开发高效高通量的新生儿肝 CYP3A7 抑制筛选检测方法。
Sci Rep. 2021 Sep 30;11(1):19443. doi: 10.1038/s41598-021-98219-x.
6
Nonadditivity in human microsomal drug metabolism revealed in a study with coumarin 152, a polyspecific cytochrome P450 substrate.在一项针对香豆素152(一种多特异性细胞色素P450底物)的研究中揭示了人类微粒体药物代谢中的非加和性。
Xenobiotica. 2020 Dec;50(12):1393-1405. doi: 10.1080/00498254.2020.1775913. Epub 2020 Jul 26.
7
Conformational selection dominates binding of steroids to human cytochrome P450 17A1.构象选择主导甾体化合物与人细胞色素 P45017A1 的结合。
J Biol Chem. 2019 Jun 28;294(26):10028-10041. doi: 10.1074/jbc.RA119.008860. Epub 2019 May 9.
8
Digging Deeper into CYP3A Testosterone Metabolism: Kinetic, Regioselectivity, and Stereoselectivity Differences between CYP3A4/5 and CYP3A7.深入探究 CYP3A 睾酮代谢:CYP3A4/5 和 CYP3A7 的动力学、区域选择性和立体选择性差异。
Drug Metab Dispos. 2017 Dec;45(12):1266-1275. doi: 10.1124/dmd.117.078055. Epub 2017 Oct 6.
9
7,8-benzoflavone binding to human cytochrome P450 3A4 reveals complex fluorescence quenching, suggesting binding at multiple protein sites.7,8-苯并黄酮与人细胞色素 P450 3A4 的结合揭示了复杂的荧光猝灭,表明在多个蛋白质结合部位结合。
J Biomol Struct Dyn. 2018 Mar;36(4):841-860. doi: 10.1080/07391102.2017.1301270. Epub 2017 Mar 20.
10
Current Approaches for Investigating and Predicting Cytochrome P450 3A4-Ligand Interactions.研究与预测细胞色素P450 3A4-配体相互作用的当前方法
Adv Exp Med Biol. 2015;851:83-105. doi: 10.1007/978-3-319-16009-2_3.